Literature DB >> 18824902

Cerebral blood flow thresholds for cerebral ischemia in traumatic brain injury. A systematic review.

Marco Botteri1, Elisabetta Bandera, Cosetta Minelli, Nicola Latronico.   

Abstract

BACKGROUND: Reduction of cerebral blood flow plays a crucial role in causing posttraumatic cerebral ischemia. However, the methodologic adequacy of studies from which currently used cerebral blood flow thresholds in traumatic brain injury have been derived has not been evaluated.
OBJECTIVE: To systematically evaluate the evidence available on cerebral blood flow thresholds and its methodologic adequacy in adults with traumatic brain injury.
METHODS: Included were primary studies on adults with traumatic brain injury in which cerebral blood flow thresholds were evaluated and reported, and follow-up brain computed tomography or magnetic resonance imaging was used as the gold standard for diagnosing the finally infarcted area.
RESULTS: Among the 53 diagnostic studies identified, 31 did not report any threshold value, whereas 20 studies used thresholds derived from the literature, mainly animal or clinical studies on ischemic stroke. One study measured cerebral blood flow thresholds, but did not use accepted neuroradiological criteria for the diagnosis of posttraumatic cerebral ischemia. The remaining study fulfilled all methodologic inclusion criteria, but was restricted to 14 patients with severe traumatic brain injury and cerebral contusion. This study proposed a cerebral blood flow threshold of 15 mL/100 mL/min, with sensitivity and specificity of 43% and 95%, respectively.
CONCLUSIONS: Cerebral blood flow thresholds for the diagnosis of posttraumatic cerebral ischemia are based on weak evidence, and cannot be recommended.

Entities:  

Mesh:

Year:  2008        PMID: 18824902     DOI: 10.1097/CCM.0b013e31818bd7df

Source DB:  PubMed          Journal:  Crit Care Med        ISSN: 0090-3493            Impact factor:   7.598


  8 in total

Review 1.  Alternative clinical trial design in neurocritical care.

Authors:  Christos Lazaridis; Andrew I R Maas; Michael J Souter; Renee H Martin; Randal M Chesnut; Stacia M DeSantis; Gene Sung; Peter D Leroux; Jose I Suarez
Journal:  Neurocrit Care       Date:  2015-06       Impact factor: 3.210

2.  Pediatric sports-related concussion produces cerebral blood flow alterations.

Authors:  Todd A Maugans; Chad Farley; Mekibib Altaye; James Leach; Kim M Cecil
Journal:  Pediatrics       Date:  2011-11-30       Impact factor: 7.124

3.  Fluid responsiveness and brain tissue oxygen augmentation after subarachnoid hemorrhage.

Authors:  Pedro Kurtz; Raimund Helbok; Sang-Bae Ko; Jan Claassen; J Michael Schmidt; Luis Fernandez; R Morgan Stuart; E Sander Connolly; Neeraj Badjatia; Stephan A Mayer; Kiwon Lee
Journal:  Neurocrit Care       Date:  2014-04       Impact factor: 3.210

4.  Cerebral Blood Flow Deviations in Critically Ill Patients: Potential Insult Contributing to Ischemic and Hyperemic Injury.

Authors:  Marat Slessarev; Ossama Mahmoud; Christopher W McIntyre; Christopher G Ellis
Journal:  Front Med (Lausanne)       Date:  2021-01-20

5.  Defining Hypoperfusion in Chronic Aphasia: An Individualized Thresholding Approach.

Authors:  Noelle T Abbott; Carolyn J Baker; Conan Chen; Thomas T Liu; Tracy E Love
Journal:  Brain Sci       Date:  2021-04-13

Review 6.  A Precision Medicine Agenda in Traumatic Brain Injury.

Authors:  Jovany Cruz Navarro; Lucido L Ponce Mejia; Claudia Robertson
Journal:  Front Pharmacol       Date:  2022-03-16       Impact factor: 5.810

7.  Administration of S-nitrosoglutathione after traumatic brain injury protects the neurovascular unit and reduces secondary injury in a rat model of controlled cortical impact.

Authors:  Mushfiquddin Khan; Yeong-Bin Im; Anandakumar Shunmugavel; Anne G Gilg; Ramanpreet K Dhindsa; Avtar K Singh; Inderjit Singh
Journal:  J Neuroinflammation       Date:  2009-11-04       Impact factor: 8.322

8.  Reactive oxygen species-activated nanoprodrug of Ibuprofen for targeting traumatic brain injury in mice.

Authors:  Morgan A Clond; Bong-Seop Lee; Jeffrey J Yu; Matthew B Singer; Takayuki Amano; Alexander W Lamb; Doniel Drazin; Babak Kateb; Eric J Ley; John S Yu
Journal:  PLoS One       Date:  2013-04-24       Impact factor: 3.240

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.